TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Ventas ( (VTR) ) just unveiled an update.
On November 17, 2025, Ventas, Inc. announced the planned retirement of Peter J. Bulgarelli, Executive Vice President of Outpatient Medical & Research and CEO of Lillibridge Healthcare Services, effective May 1, 2026. Bulgarelli has been pivotal in enhancing Ventas’s competitive edge and tenant satisfaction, and his departure will initiate a search for a successor to ensure a seamless transition, maintaining the company’s growth trajectory and industry leadership.
The most recent analyst rating on (VTR) stock is a Buy with a $91.00 price target. To see the full list of analyst forecasts on Ventas stock, see the VTR Stock Forecast page.
Spark’s Take on VTR Stock
According to Spark, TipRanks’ AI Analyst, VTR is a Neutral.
Ventas receives a solid overall score driven by strong earnings call performance and positive technical indicators. However, the high P/E ratio raises valuation concerns, and financial performance is moderate due to declining profit margins and low return on equity. The company’s strategic focus on senior housing and improved leverage are positive factors.
To see Spark’s full report on VTR stock, click here.
More about Ventas
Ventas, Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust focused on providing exceptional environments for an aging population. With around 1,400 properties across North America and the UK, Ventas plays a crucial role in the longevity economy, driven by its senior housing communities, outpatient medical buildings, research centers, and healthcare facilities.
Average Trading Volume: 2,765,252
Technical Sentiment Signal: Buy
Current Market Cap: $37.54B
See more data about VTR stock on TipRanks’ Stock Analysis page.